US OptionsDetailed Quotes
APLS240816C30000
- 7.31
- +1.21+19.84%
15min DelayClose Aug 16 15:59 ET
7.39High7.31Low
7.39Open6.10Pre Close2 Volume11 Open Interest30.00Strike Price1.47KTurnover1935.91%IV0.16%PremiumAug 16, 2024Expiry Date7.25Intrinsic Value100Multiplier-1DDays to Expiry0.06Extrinsic Value100Contract SizeAmericanOptions Type0.9538Delta0.0194Gamma5.07Leverage Ratio-13.2282Theta0.0000Rho4.83Eff Leverage0.0002Vega
Apellis Pharmaceuticals Stock Discussion
Sign in to post a comment
$Emergent BioSolutions (EBS.US)$👀 big news out WHO Says Expert Committee Will Propose Adopti - moomoo $Apellis Pharmaceuticals (APLS.US)$ $Puma Biotechnology (PBYI.US)$ $Novocure (NVCR.US)$
1
$Apellis Pharmaceuticals (APLS.US)$ CORRECTION: Apellis Pharmaceuticals Q2 2024 GAAP EPS $(0.30) Beats $(0.32) Estimate, Sales $199.70M Beat $191.51M Estimate
2
$Apellis Pharmaceuticals (APLS.US)$ 🥱 as i was saying the other day
1
4
2X 
$Apellis Pharmaceuticals (APLS.US)$ i made a lot of money on this stock
1
$Apellis Pharmaceuticals (APLS.US)$ I'm shocked this had not done anything. it hit bottom at 19.83 after the big scare panic sell off from mid 80s , bounce back up past 70. stupid corporate keeps selling off scaring investors. this is actually bargain price for this company
2
No comment yet
EZ_money OP : Vaccine developers for monkeypox include Bavarian Nordic (OTCPK:BVNKF) (OTCPK:BVNRY), Emergent BioSolutions (EBS), and Chimerix (CMRX).